Links

Only ⅔ of FDA-approved biosimilars have launched.Measles outbreak continues.UnitedHealth profits fall.Super-Earths.‘Bone Collector’ caterpillars.NFL Draft comes to Green Bay.

Read More

Hospitals are Incompetent Monopolists!

By JEFF GOLDSMITH The health policy community is obsessed with hospital mergers. In a recent paper which I critiqued, the operating thesis was that hospital mergers are conspiracies in restraint of trade, enabling hospitals to extract rent from helpless local employers and patients. This logic leads directly to advocacy (lavishly funded by Arnold Ventures philanthropy) of hospital rate…

Read More

Cost impact of BTKi selection in Medicare patients with CLL

That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…

Read More

Turquoise Health Snags $40M to Simplify Healthcare Contracts & Payments

Turquoise Health raised $40 million in a Series C round to expand beyond price transparency into managing healthcare contracts. The startup’s platform aims to simplify payer–provider agreements, reduce administrative waste and enable patients to see guaranteed upfront prices. The post Turquoise Health Snags $40M to Simplify Healthcare Contracts & Payments appeared first on MedCity News.

Read More